122 related articles for article (PubMed ID: 8231902)
1. Effects of oophorectomy and hormone replacement therapy on pituitary-gonadal function.
Castelo-Branco C; Martínez de Osaba MJ; Vanrezc JA; Fortuny A; González-Merlo J
Maturitas; 1993 Sep; 17(2):101-11. PubMed ID: 8231902
[TBL] [Abstract][Full Text] [Related]
2. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison.
Castelo-Branco C; Martínez de Osaba MJ; Fortuny A; Iglesias X; González-Merlo J
J Reprod Med; 1995 Aug; 40(8):556-60. PubMed ID: 7473451
[TBL] [Abstract][Full Text] [Related]
3. Effects of oophorectomy and hormone replacement therapy on plasma lipids.
Castelo-Branco C; Casals E; Sanllehy C; González-Merlo J; Iglesias X
Maturitas; 1993 Sep; 17(2):113-22. PubMed ID: 8231903
[TBL] [Abstract][Full Text] [Related]
4. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.
Schlegel W; Petersdorf LI; Junker R; Schulte H; Ebert C; Von Eckardstein A
Clin Endocrinol (Oxf); 1999 Nov; 51(5):643-51. PubMed ID: 10594527
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
Castelo-Branco C; Palacios S; Martinez de Osaba MJ; Balasch J; Fortuny A; Vanrell J
Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
8. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
Mathur RS; Landgrebe SC; Moody LO; Semmens JP; Williamson HO
Maturitas; 1985 Jul; 7(2):129-33. PubMed ID: 3929023
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
[TBL] [Abstract][Full Text] [Related]
10. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
11. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
Castelo-Branco C; Puerto B; Durán M; Gratacós E; Torné A; Fortuny A; Vanrell JA
Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
[TBL] [Abstract][Full Text] [Related]
12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
13. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
Odmark IS; Carlström K; Jonsson B; Jonasson AF
Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels.
Serin IS; Ozçelik B; Başbuğ M; Aygen E; Kula M; Erez R
Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):222-5. PubMed ID: 11788176
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
16. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
Lemay A; Dodin S; Cédrin I; T-Lemay L
Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
[TBL] [Abstract][Full Text] [Related]
17. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D; Smith S; Zacur H
Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
[TBL] [Abstract][Full Text] [Related]
18. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
[TBL] [Abstract][Full Text] [Related]
19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
20. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]